Uncertainty in the impact of liver support systems in acute-on-chronic liver failure: a systematic review and network meta-analysis

医学 生物人工肝装置 荟萃分析 随机对照试验 协议(科学) 梅德林 贝叶斯网络 肝衰竭 排名(信息检索) 肝移植 内科学 重症监护医学 外科 移植 人工智能 计算机科学 病理 替代医学 体外 生物化学 法学 政治学 肝细胞 化学
作者
Klementina Ocskay,Anna Kanjo,Noémi Gede,Zsolt Szakács,Gabriella Pár,Bálint Mihály Erőss,Jan Stange,Steffen R Mitzner,Péter Hegyi,Zsolt Molnár
出处
期刊:Annals of Intensive Care [Springer Nature]
卷期号:11 (1): 10-10 被引量:69
标识
DOI:10.1186/s13613-020-00795-0
摘要

BACKGROUND: The role of artificial and bioartificial liver support systems in acute-on-chronic liver failure (ACLF) is still controversial. We aimed to perform the first network meta-analysis comparing and ranking different liver support systems and standard medical therapy (SMT) in patients with ACLF. METHODS: The study protocol was registered with PROSPERO (CRD42020155850). A systematic search was conducted in five databases. We conducted a Bayesian network meta-analysis of randomized controlled trials assessing the effect of artificial or bioartificial liver support systems on survival in patients with ACLF. Ranking was performed by calculating the surface under cumulative ranking (SUCRA) curve values. The RoB2 tool and a modified GRADE approach were used for the assessment of the risk of bias and quality of evidence (QE). RESULTS: In the quantitative synthesis 16 trials were included, using MARS®, Prometheus®, ELAD®, plasma exchange (PE) and BioLogic-DT®. Overall (OS) and transplant-free (TFS) survival were assessed at 1 and 3 months. PE significantly improved 3-month OS compared to SMT (RR 0.74, CrI: 0.6-0.94) and ranked first on the cumulative ranking curves for both OS outcomes (SUCRA: 86% at 3 months; 77% at 1 month) and 3-month TFS (SUCRA: 87%) and second after ELAD for 1-month TFS (SUCRA: 76%). Other comparisons did not reach statistical significance. QE was moderate for PE concerning 1-month OS and both TFS outcomes. Other results were of very low certainty. CONCLUSION: PE seems to be the best currently available liver support therapy in ACLF regarding 3-month OS. Based on the low QE, randomized trials are needed to confirm our findings for already existing options and to introduce new devices.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
华仔的应助被小艾同学采纳,获得10
1秒前
1秒前
bkagyin的应助被冷酷的雍采纳,获得30
1秒前
1秒前
banana发布了新的文献求助100
2秒前
郁离完成签到 ,获得积分10
2秒前
2秒前
2秒前
SSS完成签到,获得积分10
2秒前
李小明发布了新的文献求助30
3秒前
霸气的赛凤完成签到,获得积分10
3秒前
丘比特的应助被黑米粥采纳,获得200
4秒前
Owen的应助被黑米粥采纳,获得200
4秒前
小马甲的应助被黑米粥采纳,获得200
4秒前
sanvva的应助被黑米粥采纳,获得200
4秒前
sunnymoon的应助被黑米粥采纳,获得200
4秒前
脑洞疼的应助被黑米粥采纳,获得200
4秒前
极限001的应助被黑米粥采纳,获得200
4秒前
sunnymoon的应助被黑米粥采纳,获得200
4秒前
sunnymoon的应助被黑米粥采纳,获得200
4秒前
放开那只大熊猫的应助被黑米粥采纳,获得200
4秒前
amy发布了新的文献求助10
5秒前
5秒前
诚心的凡雁的应助被张航源采纳,获得10
5秒前
沉沉叠叠发布了新的文献求助10
5秒前
行则将至发布了新的文献求助10
6秒前
苏苏诺诺2023完成签到,获得积分10
6秒前
哈基米德发布了新的文献求助10
6秒前
爱吃可可小方的夜神完成签到,获得积分10
6秒前
dragon关注了科研通微信公众号
7秒前
catqishi发布了新的文献求助10
7秒前
kingham发布了新的文献求助10
7秒前
cyyyyer发布了新的文献求助10
8秒前
小透明完成签到 ,获得积分10
9秒前
小白发布了新的文献求助10
9秒前
9秒前
调皮芝麻发布了新的文献求助10
10秒前
10秒前
11秒前
倒数第二完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183694
求助须知:如何正确求助?哪些是违规求助? 9572963
关于积分的说明 21828306
捐赠科研通 7780864
什么是DOI,文献DOI怎么找? 3434057
关于科研通互助平台的介绍 2558257
邀请新用户注册赠送积分活动 2480541